A clinical study to assess the bioavailability, tolerability, pharmacokinetics and safety of a solid dose injection of octreotide compared with a reference product
Phase of Trial: Phase I
Latest Information Update: 18 Oct 2017
At a glance
- Drugs Octreotide (Primary)
- Indications Acromegaly
- Focus Pharmacokinetics; Proof of concept
- Sponsors Glide Technologies
- 28 Jun 2016 Results published in a Glide Technologies media release.
- 28 Jun 2016 According to a Glide Technologies media release, status changed from recruiting to completed.
- 19 May 2016 Status changed from planning to recruiting, according to Glide Technologies media release.